NewsBenzingaMorgan Stanley mantiene il rating Equal-Weight su Aptiv e abbassa il prezzo obiettivo a 45 dollari Morgan Stanley mantiene il rating Equal-Weight su Aptiv e abbassa il prezzo obiettivo a 45 dollari Benzinga 2026.11.04 17:57 (GMT+0) Open on Benzinga Other news A YC startup is putting $1M behind five unsolved materials science problems for AI KeyBanc Just Downgraded Vistra Stock. Here's Why. Gen Digital Stock: Is Wall Street Bullish or Bearish? Karyopharm Therapeutic Common Shares To Be Suspended, Effective Nov. 11; To Trade On OTC Under KPTIQ Ticker Cantor Fitzgerald Maintains Overweight on Hut 8, Lowers Price Target to $127 Why Is Joby Aviation Stock Surging Thursday?
Karyopharm Therapeutic Common Shares To Be Suspended, Effective Nov. 11; To Trade On OTC Under KPTIQ Ticker
